Dynatrace Sees Q3 Adjusted EPS of USD 0.44-0.45
Dynatrace's Q3 adjusted EPS outlook is USD 0.44-0.45, versus an IBES estimate of USD 0.5.
Related stories
Amgen Raises 2026 Revenue View to $38.9B-$39.7B
Amgen had previously seen 2026 revenue of $38.2B to $39.4B.
M impact | EARNINGS | Nov 03, 2026, 09:07 PM UTC
AtriCure Q3 Adjusted EPS $0.18 vs. IBES Estimate -0.05
M impact | EARNINGS | Nov 03, 2026, 09:02 PM UTC
Skyworks Q4 Adjusted EPS USD 1.28 vs. IBES Estimate USD 1.27
Reuters reports Skyworks Q4 EPS of USD 0.15.
L impact | EARNINGS | Nov 03, 2026, 09:02 PM UTC
AtriCure Issues FY Adjusted EBITDA Outlook
AtriCure's fiscal-year adjusted EBITDA outlook is USD 91–94 million, versus the IBES estimate of USD 87.5 million.
M impact | EARNINGS | Nov 03, 2026, 09:02 PM UTC
Avis Budget Group Reports 3Q Net Income of $183M
M impact | EARNINGS | Nov 03, 2026, 09:02 PM UTC
Ramaco Resources Q3 Cash Margin Falls 30% to $16 Per Ton
Ramaco sold 1.1 million tons in Q3 2026, up 23% year over year. Realized pricing was $120 per ton, consistent with Q3 2025, and liquidity was $374.7 million, up approximately 38%.
M impact | EARNINGS | Nov 03, 2026, 09:02 PM UTC